On the other hand, other studies reported a negative association between intrahepatic IL-22 levels and liver inflammation as well as fibrosis in CHB patients (193, 224), probably due to the capacity of IL-22 to promote the survival of hepatocytes and induce the proliferation of LPCs (224). Here, IL22 is linked to fibrosis.